Physician profile
Erica Stockwell
NPI 1750680310
$320,924.46
in general payments reported to CMS, 2019-2025
36 companies · $77K in 2025
The $77K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $13K · 2021: $49K · 2022: $71K · 2023: $46K · 2024: $52K · 2025: $77K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $91K · Consulting Fee: $34K · Travel and Lodging: $28K · Education: $12K · Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $90,827.50 |
| Consulting Fee | $34,075.00 |
| Travel and Lodging | $27,708.29 |
| Education | $12,336.19 |
| Food and Beverage | $10,953.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $169,164.63 | 2019-2025 | Gelpoint V-Path |
| Momentis Surgical INC. | $40,623.41 | 2021-2025 | Anovo Surgical System |
| Intuitive Surgical, INC. | $35,363.45 | 2019-2025 | |
| Distalmotion US | $24,485.32 | 2024-2025 | Dexter L6 Robot |
| Astellas Pharma US INC | $20,650.40 | 2023-2025 | Veozah |
| Astellas Pharma Global Development | $8,788.61 | 2024-2025 | Veozah |
| Meditrina | $5,077.14 | 2023-2025 | |
| Gynesonics, INC. | $3,075.44 | 2021-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Avanos Medical | $2,469.30 | 2019-2022 | |
| Cmr Surgical, INC. | $2,205.90 | 2025 | Versius Surgical System (Versius Plus) |
| Arthrex, INC. | $1,781.04 | 2021-2025 | Arthrex |
| Abbvie INC. | $1,127.89 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Boston Scientific Corporation | $839.15 | 2019 | |
| Acessa Health INC. | $764.82 | 2019 | |
| Asensus Surgical, INC. | $730.81 | 2021-2023 | Senhance |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $596.16 | 2019-2023 | Omni Hysteroscope, Novasure, Thinprep 2000 Processor |
| Coopersurgical, INC. | $378.67 | 2019-2024 | Mara Console |
| Covidien Lp | $338.34 | 2020 | |
| Coloplast Corp | $246.22 | 2019 | |
| Channel Medsystems, INC. | $211.16 | 2025 | |
| Medtronic, INC. | $194.53 | 2022 | |
| Ethicon US, LLC | $194.02 | 2020-2021 | |
| Pfizer INC. | $165.04 | 2022-2023 | |
| Myovant Sciences INC. | $155.16 | 2021-2022 | |
| Conmed Corporation | $145.83 | 2019 | |
| Lsi Solutions INC | $138.03 | 2019 | |
| Olympus Corporation of The Americas | $137.00 | 2023 | Pneumoliner, Olympus |
| Daiichi Sankyo INC. | $125.21 | 2019 | |
| Heron Therapeutics, INC. | $125.00 | 2022 | |
| Teleflex LLC | $122.96 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $113.46 | 2024 | Exparel |
| Ethicon INC. | $108.00 | 2020 | |
| Minerva Surgical, INC | $96.51 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $93.80 | 2025 | |
| Sumitomo Pharma America, INC. | $62.05 | 2023 | Myfembree |
| Caldera Medical, INC | $30.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erica Stockwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.